Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept Transition from Cyclosporine in Psoriasis
NCT00143806Phase 2Completed
- Sponsor
- University of Medicine and Dentistry of New Jersey
- Start
- Oct 2003
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alefacept in psoriasis, sponsored by University of Medicine and Dentistry of New Jersey. Primary endpoints: Static Physician's Global Assessment and Dermatology Life Quality Index. Started Oct 2003; status: completed.
02
Drugs
alefacept
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00143806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00143806.